AMBEA Ambea AB (publ)
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for adults, children, and youth, as well as personal assistance under the Stendi brand. It also offers disability care, nursing home, home care, and rehabilitation services under the Altiden brand. In addition, the company offers staff solutions for social welfare services, including ambulatory care teams and student health service staffing under the Klara brand. Further, it develops and offers skills development training and coaching services in disability care, social services field, aged care, and schools under the Lära brand; and care youth and families as well as residential facilities personal assistance, daily activity units and rehabilitation for people with physical and intellectual disabilities, and psychosocial problems under the Validia brand. Ambea AB (publ)was formerly known as H-Careholding AB and changed its name to Ambea AB (publ) in September 2007. Ambea AB (publ) was incorporated in 1993 and is headquartered in Solna, Sweden with an additional location in Nivå, Denmark.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Ambea (STO: AMBEA)
›
Ambea (STO: AMBEA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 41,000 employees.
The shares were at 193.30 SEK on 19 November 2026, up 51.7% over 52 weeks. Its 52-week range is 112.70 SEK to 197.50 SEK: the price is 2.1% below the high and 71.5% above the low.
At a market capitalisation of 16.13B SEK, it trades at 18.4 times trailing earnings and 22.9 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 22% for AMBEA. It pays a dividend yielding 1.38% (it pays out 25% of its earnings), against a median of 0.75% among the dividend payers in that peer group.
Ambea reports return on equity of 12.8%, an operating margin of 8.8% and revenue up 8.1% year over year.
Its debt exceeds its cash by 13.82B SEK, a debt-to-equity ratio of 2.43. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 222.67 SEK is 15.2% above the current price. The next earnings report is expected on 11 February 2027.